NCT00089999 - Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Neoplasms, Breast

Interventions

DRUG

Lapatinib

Trial Locations (31)

100

GSK Investigational Site, Taipei

114

GSK Investigational Site, Taipei

10450

GSK Investigational Site, Tanjong Bungah

11200

GSK Investigational Site, Tanjong Bungah

16150

GSK Investigational Site, Kubang Kerian

33021

GSK Investigational Site, Hollywood

54000

GSK Investigational Site, Karachi

59100

GSK Investigational Site, Bandar Tun Razak, Cheras

70140

GSK Investigational Site, Ixtaltepec / Espinal

74800

GSK Investigational Site, Karachi

97500

GSK Investigational Site, Mérida

110085

GSK Investigational Site, Delhi

169610

GSK Investigational Site, Singapore

258500

GSK Investigational Site, Singapore

411001

GSK Investigational Site, Pune

500482

GSK Investigational Site, Hyderabad, Andhra Pradesh

7500921

GSK Investigational Site, Santiago

8380456

GSK Investigational Site, Santiago

Unknown

GSK Investigational Site, Santiago

GSK Investigational Site, Pokfulam

GSK Investigational Site, México

GSK Investigational Site, Karachi

GSK Investigational Site, Lahore

GSK Investigational Site, Rawalpindi

Lima 11

GSK Investigational Site, Lima

Lima 13

GSK Investigational Site, Lima

Lima 34

GSK Investigational Site, Lima

Callao 2

GSK Investigational Site, Callao

85-796

GSK Investigational Site, Bydogoszcz

31-115

GSK Investigational Site, Krakow

10-228

GSK Investigational Site, Olsztyn